On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $62.56, representing a -2.51% change from its previous close.

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

"The CRISPR technology was introduced as an mRNA," Coller said. "That is the critical feature that was necessary to get this ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective DNA and fix genetic diseases like sickle cell anemia, and chronic disorders ...